The novel coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), remains a global challenge. Currently …

Multiple sclerosis (MS) is a degenerative condition characterized by immune-mediated
attacks on the central nervous system (CNS), resulting in demyelination and recurring T-cell …

Disruptions in oxidative metabolism may occur in multiple sclerosis and other demyelinating
neurological diseases. The impact of demyelination on metabolic rate is also not …

The central nervous system (CNS) has been viewed as an immunologically privileged site,
but emerging works are uncovering a large array of neuroimmune interactions primarily …

Neuroinflammation is characterized by reactive microglia and astrocytes (collectively called
gliosis) in the central nervous system and is considered as one of the main pathological …

Multiple sclerosis (MS) is characterized by a targeted attack on oligodendroglia (OLG) and
myelin by immune cells, which are thought to be the main drivers of MS susceptibility. We …

A change in visual perception is a frequent early symptom of multiple sclerosis (MS), the
pathoaetiology of which remains unclear. Following a slow demyelination process caused …

Multiple sclerosis (MS) is a chronic inflammatory, demyelinating, and neurodegenerative
disease in the central nervous system (CNS). Its pathogenesis is quite complex …

Multiple sclerosis (MS) is a heterogeneous disease of the central nervous system that is
governed by neural tissue loss and dystrophy during its progressive phase, with complex …

Multiple sclerosis (MS) is a chronic inflammatory demyelinating and degenerative disorder
of the central nervous system. Accelerated brain volume loss (BVL) has emerged as a …